[1]
R, N., K, S., Ing, B., K, T. and Pa, I. 2016. EFFECTIVENESS AND TOXICITY DIFFERENCES BETWEEN THE USE OF REGIMEN CHEMOTHERAPY BLEOMYCIN-VINCRISTINE-MITOMYCIN-CISPLATIN AND BLEOMYCIN- VINCRISTINE-MITOMYCIN-CARBOPLATIN FOR THREE CYCLES IN PATIENTS CERVICAL CANCER SQUAMOUS CELL STADIUM IIB-IIIB IN SANGLAH GENERAL HOSPITAL DENPASAR BALI Research Article. Asian Journal of Pharmaceutical and Clinical Research. 9, 8 (Oct. 2016), 149–153. DOI:https://doi.org/10.22159/ajpcr.2016.v9s2.13372.